Description
The standardized extract of Black Cohosh (Actaea racemosa, formerly Cimicifuga racemosa) rhizome and root, standardized to triterpene glycoside content. Used in menopause-support and women's-health dietary supplements globally, with one of the strongest clinical evidence bases for botanical menopause management.
Light brown to dark brown free-flowing powder. Limited water solubility; freely soluble in alcohol.
We supply food-grade Black Cohosh Extract from manufacturers in China holding ISO, Halal, Kosher and other certifications relevant to the product and production. DNA-authenticated grades are available to address historical adulteration concerns.
Common market grades include 2.5 percent Triterpene Glycosides (the workhorse supplement grade matching the Remifemin clinical reference), 5 percent Triterpene Glycosides (premium grade), 8 percent Triterpene Glycosides (high-end concentrated grade), and 4:1 to 10:1 unstandardized ratio extracts.
Bulk and reduced-MOQ shipments. Batch-level COA covering total triterpene glycosides (HPLC), 23-epi-26-deoxyactein content, DNA species authentication (where requested), residual solvents, heavy metals, pesticides, and microbiology.
Introduction
Black Cohosh is a flowering plant native to eastern North America, where indigenous peoples used the root for women's health complaints, snakebite, and rheumatism. Modern commercial development began in Germany in the 1950s with the Remifemin standardized extract, which became the most-studied botanical menopause product globally.
Industrial production proceeds by ethanol or hydroalcoholic extraction of dried Black Cohosh rhizome, followed by purification and standardization to triterpene glycoside content (typically 2.5 to 8 percent expressed as 23-epi-26-deoxyactein).
Regulated as a prescription herbal medicine in Germany and several other markets; sold as a dietary supplement in the U.S. and most other markets. The European Medicines Agency has issued monographs supporting use for menopausal symptoms.
Clinical evidence supports modest symptom relief for hot flashes and night sweats in peri- and postmenopausal women, particularly at the 40 mg standardized extract dose used in pivotal trials. The mechanism is not estrogenic, distinguishing Black Cohosh from soy isoflavone and red clover phytoestrogen approaches.
Strategic positioning is dominated by menopause-support dietary supplements globally, the dominant non-hormonal natural product category for menopausal symptom management.
Where it is used
- Menopause-support dietary supplements: hot-flash and night-sweat-positioned formulations (the dominant commercial application)
- Women's-health and hormone-balance supplement formulations
- Pharmaceutical applications: licensed herbal medicine in Germany and several other markets
- Premenstrual symptom support supplements
- Combination women's-health formulations with soy isoflavones, red clover, and other phytoestrogens
- Bone-health supplements positioned for postmenopausal women
- Beauty-from-within supplements for mature women
Technical data
| Item | Specification |
|---|---|
| Appearance | Light brown to dark brown free-flowing powder |
| Total triterpene glycosides (HPLC) | 2.5% / 5% / 8% (grade dependent) |
| Loss on drying | ≤ 5.0% |
| Residue on ignition | ≤ 6.0% |
| Heavy metals (as Pb) | ≤ 2 mg/kg |
| DNA species authentication | Confirmed Actaea racemosa (where requested) |
| Total plate count | ≤ 10000 cfu/g |
| Source | Actaea racemosa dried rhizome and roots |
Ready to discuss business?
Send us your spec and requirement. We will respond with availability and pricing within 24 hours.